Startseite>>Signaling Pathways>> MAPK Signaling>> MEK1/2>>GSK1790627

GSK1790627

Katalog-Nr.GC69191

GSK1790627 ist das N-Deacetylierungsprodukt von Trametinib. Trametinib ist ein oral aktiver MEK-Inhibitor, der die Autophagie aktivieren und Zelltod induzieren kann.

Products are for research use only. Not for human use. We do not sell to patients.

GSK1790627 Chemische Struktur

Cas No.: 871701-87-0

Größe Preis Lagerbestand Menge
10mg
342,00 $
Auf Lager
25mg
720,00 $
Auf Lager
50mg
1.152,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

Bewertungen

Review for GSK1790627

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GSK1790627

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.